From Wikipedia,
the free encyclopedia.
Serono is a
biotechnology
company headquartered in
Geneva,
Switzerland. The company was
incorporated in 1987 and the
holding company, Ares-Serono S.A.,
changed its name to Serono S.A. in
May 2000.[1]
The company develops and markets
pharmaceuticals in the fields
of
Reproductive Health,
Multiple Sclerosis and Growth
&
Metabolism. It is world-leader
in the infertility market with an
estimated market share of 60%,
making it the third largest
biotechnology company in the
world. Serono's most important
product accounted for 31.6% of the
company's sales in 2004. Currently
the company has a partnership in
product development with
Genentech Inc., a US
biotechnology company.
Facilities
The headquarters is located in
Geneva, Switzerland. Research
and development facilities are
maintained in Geneva, Switzerland,
Boston, USA,
Évry, France and
Ardea, Italy. Main
manufacturing sites are in
Switzerland, Italy, Spain and
France; a fifth facility in Israel
was closed in 2004 owing to its
obsolescence.[2]
Notes
- ^
2002 Form 20-F. Retrieved
July 3, 2005.
- ^
2004 Form 20-F. Retrieved
July 3, 2005.
